MitrAssist Lifesciences announced clinical results for its new transthoracic heart valve (THV) system for TAVI procedures.

A heart attack and stroke are both serious health conditions that occur when there's a blockage in the arteries (blood ...

The global intracardiac imaging market is on the brink of substantial expansion, with a projected compound annual growth rate ...

Updated guidelines on allogeneic hematopoietic stem cell transplantation for myelofibrosis examine spleen-related ...

Three-year-old Simeon Jeremiah, diagnosed with heart defects, needs urgent surgery costing N5m. Simeon was born with ...

Assessing right ventricular diastolic function is crucial in cardiac surgery, as it significantly impacts long-term prognosis. Typically, RV diastolic dysfunction is evaluated using criteria ...

Extending the simple CT scan administered to all acute stroke patients to include the upper part of the heart increased ...

The incidence of breast cancer has increased from 900 000 to 2.3 million new annual cases over the last 25 years. The 5-year ...

The 2024 edition of Transcatheter Cardiovascular Therapeutics (TCT) once again highlighted significant innovations in ...

A recent study published in Kidney Research and Clinical Practice has shed light on the impact of sacubitril-valsartan ...

MitrAssist Lifesciences, a leader in innovative cardiovascular medical devices, today unveiled the initial clinical results ...